Stock Analiz

Zymeworks Inc. (ZYME) financials: revenue, earnings and cash flow

Fiscal 2020–2025 + TTM · from SEC filings · data as of November 13, 2026

Summary

Zymeworks’s revenue went from $39M in fiscal 2020 to $106M in fiscal 2025, growth of about 22.2% a year.

Net income in fiscal 2025 was -$81M, a net margin of -76.6%; the best year in this period was 2022 with $124M.

Over the twelve months to September 30, 2026, revenue was $266M and net income $43M.

Free cash flow was -$35M in fiscal 2025 and positive in 1 of the 6 years shown.

The diluted share count rose 50% over the period (dilution).

Revenue, profit and cash flow by year

Revenue
2020: $39M20202021: $27M20212022: $412M20222023: $76M20232024: $76M20242025: $106M2025$106M
Net income
2020: -$181M20202021: -$212M20212022: $124M20222023: -$119M20232024: -$123M20242025: -$81M2025-$81M
Free cash flow
2020: -$156M20202021: -$205M20212022: $136M20222023: -$121M20232024: -$112M20242025: -$35M2025-$35M
EPS (diluted)
2020: $-3.5820202021: $-4.6120212022: $1.9020222023: $-1.7220232024: $-1.6220242025: $-1.082025$-1.08

Income statement

Fiscal yearTTM202520242023202220212020
Revenue$266M$106M$76M$76M$412M$27M$39M
Gross profit———————
Operating income$44M-$93M-$137M-$138M$131M-$216M-$187M
Net income$43M-$81M-$123M-$119M$124M-$212M-$181M
EPS (diluted)$0.52$-1.08$-1.62$-1.72$1.90$-4.61$-3.58
R&D$129M$137M$135M$144M$209M$200M$171M
Revenue growth—+38.9%+0.4%−81.6%+1446.0%−31.5%—

Cash flow

Fiscal yearTTM202520242023202220212020
Operating cash flow-$112M-$33M-$110M-$118M$144M-$192M-$151M
Capital spending-$870000-$2M-$2M-$2M-$8M-$12M-$4M
Free cash flow-$113M-$35M-$112M-$121M$136M-$205M-$156M
Dividends paid—$0$0$0$0$0$0
Buybacks$166M$42M$30M$0$0——
Stock-based pay$50M$28M$18M$8M$4M$11M$29M

Balance sheet

Fiscal yearTTM202520242023202220212020
Cash—$41M$66M$374M$492M$253M$242M
Debt—$18M$18M$27M$28M$32M—
Equity—$269M$339M$465M$493M$249M$410M
Total assets—$347M$463M$581M$649M$389M—
Shares (diluted)76M75M76M69M65M52M50M

Margins and returns

Fiscal yearTTM202520242023202220212020
Gross margin———————
Operating margin16.6%-87.3%-179.7%-181.6%31.6%-808.2%-481.3%
Net margin16.3%-76.6%-160.8%-156.1%30.1%-794.0%-463.5%
FCF margin-42.4%-32.6%-146.8%-158.9%33.0%-767.8%-399.8%
ROIC—-25.5%-30.3%-28.0%23.0%-76.5%-36.1%
ROE—-30.2%-36.2%-25.5%25.2%-85.0%-44.0%

Frequently asked questions

What is Zymeworks’s annual revenue?

$106M in fiscal 2025 and $266M over the twelve months to September 30, 2026.

How much profit does Zymeworks make?

Net income was -$81M in fiscal 2025 (net margin -76.6%).

Is Zymeworks’s revenue growing?

Yes: revenue rose 38.9% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.